AMERICAN JOURNAL OF PSYCHIATRY, vol.170, no.11, pp.1249-1262, 2013 (SCI-Expanded)
Objective: The risk-benefit profile of antidepressant medications in bipolar disorder is controversial. When conclusive evidence is lacking, expert consensus can guide treatment decisions. The International Society for Bipolar Disorders (ISBD) convened a task force to seek consensus recommendations on the use of antidepressants in bipolar disorders.